Launching in the US early 2026!
* two nasal spray formulations—Spontan and Roxus—both based on the proven compound vardenafil.
* LTR Pharma has announced that it will launch its new product Roxus in the US market in the first half of 2026. Instead of waiting for full regulatory approval...